3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
69
Carcinoma, Intraductal, Noninfiltrating
9
Breast Carcinoma In Situ
6
Breast Neoplasms, Male
5
Neoplasms
3
Neoplasm Metastasis
3
Urinary Bladder Neoplasms
2
Inflammatory Breast Neoplasms
2
Sleep Wake Disorders
1
Risk Reduction Behavior
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Obesity
1
Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer
1
Mastodynia
1
Glioma
1
Fibrocystic Breast Disease
1
Fibroadenoma
1
Fatigue
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Disease Progression
1
Desmoid Tumors
1
Cystic Fibrosis
1
Cystadenocarcinoma, Serous
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Lobular
1
Bulbo-Spinal Atrophy, X-Linked
1
Breast Cancer Metastatic
1
Interventions
etoposide phosphate
2
Radiotherapy
2
fluorodopa F 18
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Perfusion Magnetic Resonance Imaging
1
Microarray Analysis
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Immunologic Techniques
1
Immunohistochemistry
1
Ifosfamide
1
Etoposide
1
Dynamic Contrast Enhanced Magnetic Resonance Imaging
1
Doxorubicin
1
Donepezil
1
Dasatinib
1
Cyproheptadine
1
Cilengitide
1
Carboplatin
1
Blotting, Western
1
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Optic Nerve Glioma
×
Tamoxifen
×
Clear all
No trials found.